Update on Pathogenesis of Glomerular Hyperfiltration in Early Diabetic Kidney Disease

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2022 Jun 6

PMID 35663316

Authors

Yang Yang

Gaosi Xu

Affiliations

Soon will be listed here.

Abstract

In the existing stages of diabetic kidney disease (DKD), the first stage of DKD is called the preclinical stage, characterized by glomerular hyperfiltration, an abnormally elevated glomerular filtration rate. Glomerular hyperfiltration is an independent risk factor for accelerated deterioration of renal function and progression of nephropathy, which is associated with a high risk for metabolic and cardiovascular disease. It is imperative to understand hyperfiltration and identify potential treatments to delay DKD progress. This paper summarizes the current mechanisms of hyperfiltration in early DKD. We pay close attention to the effect of glucose reabsorption mediated by sodium-glucose cotransporters and renal growth on hyperfiltration in DKD patients, as well as the mechanisms of nitric oxide and adenosine actions on renal afferent arterioles tubuloglomerular feedback. Furthermore, we also focus on the contribution of the atrial natriuretic peptide, cyclooxygenase, renin-angiotensin-aldosterone system, and endothelin on hyperfiltration. Proposing potential treatments based on these mechanisms may offer new therapeutic opportunities to reduce the renal burden in this population.

Citing Articles

The role of endothelin receptor antagonists in kidney disease.

Ma X, Liang Y, Chen W, Zheng L, Lin H, Zhou T Ren Fail. 2025; 47(1):2465810.

PMID: 40015728 PMC: 11869344. DOI: 10.1080/0886022X.2025.2465810.

Decline in eGFR and mortality among type II diabetic patients: a 3-year prospective cohort study from Palestine.

Jaber M, Sharabati A, Nofal K, Hassan M, Hamdan Z, Nazzal Z BMC Nephrol. 2025; 26(1):64.

PMID: 39930337 PMC: 11808952. DOI: 10.1186/s12882-025-03947-1.

Breaking Barriers: Tackling Racial and Socioeconomic Disparities in the Prescription of Life-Saving SGLT2 Inhibitors for Proteinuria.

Taylor S, Zinabu S, McMillan E, Ocampo E, Edmonds A, Lyles S Cureus. 2025; 17(1):e77159.

PMID: 39925502 PMC: 11805696. DOI: 10.7759/cureus.77159.

PM Exposure Induces Glomerular Hyperfiltration in Mice in a Gender-Dependent Manner.

Wang H, Ma L, Guo Y, Ren L, Li G, Sang N Toxics. 2025; 12(12.

PMID: 39771093 PMC: 11679005. DOI: 10.3390/toxics12120878.

Mass-spectrometry-based quantitative proteomic analysis reveals that methylglyoxal and carnosine influence oxidative stress and RNA-processing associated proteins in renal proximal tubule epithelial cells.

Liu L, Zhang S, Xu J, Cao Y, Cui D, Liu C Mol Biol Rep. 2025; 52(1):100.

PMID: 39751919 DOI: 10.1007/s11033-024-10190-8.

References

Faulhaber-Walter R, Chen L, Oppermann M, Kim S, Huang Y, Hiramatsu N . Lack of A1 adenosine receptors augments diabetic hyperfiltration and glomerular injury. J Am Soc Nephrol. 2008; 19(4):722-30. PMC: 2390969. DOI: 10.1681/ASN.2007060721. View

Sasson A, Cherney D . Renal hyperfiltration related to diabetes mellitus and obesity in human disease. World J Diabetes. 2012; 3(1):1-6. PMC: 3258534. DOI: 10.4239/wjd.v3.i1.1. View

Hallow K, Gebremichael Y, Helmlinger G, Vallon V . Primary proximal tubule hyperreabsorption and impaired tubular transport counterregulation determine glomerular hyperfiltration in diabetes: a modeling analysis. Am J Physiol Renal Physiol. 2017; 312(5):F819-F835. PMC: 5451553. DOI: 10.1152/ajprenal.00497.2016. View

Vidal-Petiot E, Courbebaisse M, Livrozet M, Correge G, Rusu T, Montravers F . Comparison of Cr-EDTA and Tc-DTPA for glomerular filtration rate measurement. J Nephrol. 2021; 34(3):729-737. DOI: 10.1007/s40620-020-00932-9. View

Vestri S, Okamoto M, de Freitas H, Aparecida Dos Santos R, Nunes M, Morimatsu M . Changes in sodium or glucose filtration rate modulate expression of glucose transporters in renal proximal tubular cells of rat. J Membr Biol. 2001; 182(2):105-12. DOI: 10.1007/s00232-001-0036-y. View

Komers R, Lindsley J, Oyama T, Schutzer W, Reed J, Mader S . Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes. J Clin Invest. 2001; 107(7):889-98. PMC: 199567. DOI: 10.1172/JCI10228. View

Benz K, Amann K . Endothelin in diabetic renal disease. Contrib Nephrol. 2011; 172:139-148. DOI: 10.1159/000328695. View

Rahmoune H, Thompson P, Ward J, Smith C, Hong G, Brown J . Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes. Diabetes. 2005; 54(12):3427-34. DOI: 10.2337/diabetes.54.12.3427. View

Magee G, Bilous R, Cardwell C, Hunter S, Kee F, Fogarty D . Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia. 2009; 52(4):691-7. DOI: 10.1007/s00125-009-1268-0. View

10.

Patinha D, Abreu C, Carvalho C, Cunha O, Mota M, Afonso J . Adenosine A and A Receptors as Targets for the Treatment of Hypertensive-Diabetic Nephropathy. Biomedicines. 2020; 8(11). PMC: 7700226. DOI: 10.3390/biomedicines8110529. View

11.

Gorboulev V, Schurmann A, Vallon V, Kipp H, Jaschke A, Klessen D . Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes. 2011; 61(1):187-96. PMC: 3237647. DOI: 10.2337/db11-1029. View

12.

Thomson S, Deng A, Bao D, Satriano J, Blantz R, Vallon V . Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes. J Clin Invest. 2001; 107(2):217-24. PMC: 199175. DOI: 10.1172/JCI10963. View

13.

Kanai Y, Lee W, You G, Brown D, Hediger M . The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose. J Clin Invest. 1994; 93(1):397-404. PMC: 293794. DOI: 10.1172/JCI116972. View

14.

Carmines P . The renal vascular response to diabetes. Curr Opin Nephrol Hypertens. 2009; 19(1):85-90. PMC: 2886724. DOI: 10.1097/MNH.0b013e32833240fc. View

15.

Yang T, Endo Y, Huang Y, Smart A, Briggs J, Schnermann J . Renin expression in COX-2-knockout mice on normal or low-salt diets. Am J Physiol Renal Physiol. 2000; 279(5):F819-25. DOI: 10.1152/ajprenal.2000.279.5.F819. View

16.

Brown R, Ollerstam A, Johansson B, Skott O, Gebre-Medhin S, Fredholm B . Abolished tubuloglomerular feedback and increased plasma renin in adenosine A1 receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol. 2001; 281(5):R1362-7. DOI: 10.1152/ajpregu.2001.281.5.R1362. View

17.

Hong S, Choi Y, Ihm S, Kim D, Choi M, Yu J . Association between metabolic parameters and glomerular hyperfiltration in a representative Korean population without chronic kidney disease. PLoS One. 2018; 13(12):e0207843. PMC: 6283579. DOI: 10.1371/journal.pone.0207843. View

18.

Gurley S, Coffman T . The renin-angiotensin system and diabetic nephropathy. Semin Nephrol. 2007; 27(2):144-52. DOI: 10.1016/j.semnephrol.2007.01.009. View

19.

Li L, Lai E, Huang Y, Eisner C, Mizel D, Wilcox C . Renal afferent arteriolar and tubuloglomerular feedback reactivity in mice with conditional deletions of adenosine 1 receptors. Am J Physiol Renal Physiol. 2012; 303(8):F1166-75. PMC: 3469676. DOI: 10.1152/ajprenal.00222.2012. View

20.

Heerspink H, Stefansson B, Correa-Rotter R, Chertow G, Greene T, Hou F . Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2020; 383(15):1436-1446. DOI: 10.1056/NEJMoa2024816. View